XENE

Xenon Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 0/10
  • Value↓ 0/10
Xenon Pharmaceuticals sales and earnings growth
XENE Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -44.85%
  • FCF Y/Y↓ -51.75%
Xenon Pharmaceuticals gross and profit margin trends
XENE Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -4612.10%
  • ROIC 5Y↓ -35.71%
Xenon Pharmaceuticals net debt vs free cash flow
XENE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Xenon Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗